IL6 and colitis: It was also reported [47] on experimental model of colitis-associated colorectal carcinoma, that NFATC2-deficient mice were protected from tumor development and show significantly reduced levels of the downstream critical proinflammatory cytokines interleukin IL21 and IL6.